Literature DB >> 25954649

To study the prevalence of impaired glucose tolerance in patients with hepatitis C virus related chronic liver disease.

Harpreet Kaur1, Parminder Singh2, Harminder Singh Pannu3, Ajit Sood4, Narender Pal Jain3, Harpreet Singh Bhoday5.   

Abstract

BACKGROUND: Hepatitis C infection is a major cause of Chronic Liver Disease and the prevalence of Diabetes Mellitus is also high. Diabetes has been hypothesised as one of Extrahepatic manifestations of Hepatitis C. AIMS AND
OBJECTIVES: The objective of our study was to study the prevalence of impaired glucose tolerance in patients with HCV related liver disease. STUDY
DESIGN: The study was a prospective study conducted over a period of one and half year in Dayanand Medical College and Hospital, Ludhiana, Punjab, India.
MATERIALS AND METHODS: The study was conducted taking total of 100 Hepatitis C virus positive patients above 40 years of age who had fasting blood glucose levels ≥110mg/dl on two occasions, 24 hours apart. These patients underwent an oral glucose tolerance test. Blood sugar levels were tested at 0 and 2 hours. Based on the findings, patients were classified to have impaired glucose tolerance if levels were between 140-200mg/dl and frank diabetes if the levels were ≥ 200mg/dl. These findings were further assessed according to age, gender, Body Mass Index (BMI) Child Turcott Pugh score and Ultrasonography findings. STATISTICAL ANALYSIS: In our study all the statistical analysis was done using simple z-test and student t-test. The p-values were calculated and the results assessed accordingly. RESULTS AND
CONCLUSION: Out of 100 patients, 78 were males and rest females. The mean age of the study group was 55.89±11.22 years. Mean BMI of males was higher than in females (21.98kg/m² v/s 20.13kg/m²). Maximum patients belonged to Child Turcott Pugh class C. Out of 100 patients,80 had cirrhosis on ultrasound. On doing Glucose Tolerance Test, 40 patients were found to have impaired glucose tolerance and one patient to be diabetic. The prevalence increased significantly as age increased and had significant relation with gender. On assessing according to BMI, there was not much significant relation but prevalence was significantly related to severity of disease.

Entities:  

Keywords:  Diabetes mellitus; Extrahepatic manifestations; Hepatitis C; Impaired glucose tolerance

Year:  2015        PMID: 25954649      PMCID: PMC4413098          DOI: 10.7860/JCDR/2015/11444.5665

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  25 in total

1.  Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C.

Authors:  Calogero Cammà; Savino Bruno; Vito Di Marco; Danilo Di Bona; Mariagrazia Rumi; Maria Vinci; Chiara Rebucci; Agostino Cividini; Giuseppe Pizzolanti; Ernesto Minola; Mario U Mondelli; Massimo Colombo; Giovanbattista Pinzello; Antonio Craxì
Journal:  Hepatology       Date:  2006-01       Impact factor: 17.425

2.  Increased prevalence of diabetes mellitus in patients with chronic hepatitis C virus infection.

Authors:  E Ozyilkan; M Arslan
Journal:  Am J Gastroenterol       Date:  1996-07       Impact factor: 10.864

Review 3.  Review article: hepatitis C virus infection and type-2 diabetes mellitus in renal diseases and transplantation.

Authors:  F Fabrizi; P Lampertico; G Lunghi; S Mangano; F Aucella; P Martin
Journal:  Aliment Pharmacol Ther       Date:  2005-03-15       Impact factor: 8.171

4.  Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection.

Authors:  S Caronia; K Taylor; L Pagliaro; C Carr; U Palazzo; J Petrik; S O'Rahilly; S Shore; B D Tom; G J Alexander
Journal:  Hepatology       Date:  1999-10       Impact factor: 17.425

5.  Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C.

Authors:  P Cacoub; C Renou; E Rosenthal; P Cohen; I Loury; V Loustaud-Ratti; A M Yamamoto; A C Camproux; P Hausfater; L Musset; P Veyssier; G Raguin; J C Piette
Journal:  Medicine (Baltimore)       Date:  2000-01       Impact factor: 1.889

6.  Insulin resistance in chronic hepatitis B and C.

Authors:  Amir Houshang Mohammad Alizadeh; Farahnaz Fallahian; Seyed Moayed Alavian; Mitra Ranjbar; Mehdi Hedayati; Farzaneh Rahimi; Hossein Khedmat; Arash Etemadi; Mohammad Reza Zali; Fereidoun Azizi
Journal:  Indian J Gastroenterol       Date:  2006 Nov-Dec

7.  Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C.

Authors:  J M Petit; J B Bour; C Galland-Jos; A Minello; B Verges; M Guiguet; J M Brun; P Hillon
Journal:  J Hepatol       Date:  2001-08       Impact factor: 25.083

8.  Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States.

Authors:  S H Mehta; F L Brancati; M S Sulkowski; S A Strathdee; M Szklo; D L Thomas
Journal:  Ann Intern Med       Date:  2000-10-17       Impact factor: 25.391

9.  Community-based study of hepatitis C virus infection and type 2 diabetes: an association affected by age and hepatitis severity status.

Authors:  Chong-Shan Wang; Shan-Tair Wang; Wei-Jen Yao; Ting-Tsung Chang; Pesus Chou
Journal:  Am J Epidemiol       Date:  2003-12-15       Impact factor: 4.897

10.  Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population.

Authors:  M E Allison; T Wreghitt; C R Palmer; G J Alexander
Journal:  J Hepatol       Date:  1994-12       Impact factor: 25.083

View more
  4 in total

1.  Chronic hepatitis C virus infection in India: Regional demographics and distribution of viral genotypes.

Authors:  Samir R Shah; P N Rao; Shiv K Sarin; Abhijit Chowdhury; Shobna Bhatia; Rajesh Dharamsi; B D Goswami; Dharmesh Kapoor; Rosang Luaia; Rajiv Mehta; Shrikant Mukewar; V G Mohan Prasad; Ramesh Roop Rai; Sanjiv Saigal; Devendra Singh; Nirupama Trehanpati; Sandra Chen; Anuj Gaggar; Steven J Knox; G Mani Subramanian; Shivaram Prasad Singh; Ajit Sood; Joy Varghese; Raj Vigna Venugopal
Journal:  Indian J Gastroenterol       Date:  2016-11-15

2.  Genetic Polymorphism of CYP27B1-1260 as Associated With Impaired Fasting Glucose in Patients With Chronic Hepatitis C Undergoing Antiviral Therapy.

Authors:  Derong Sun; Wenqian Qi; Song Wang; Xu Wang; Yonggui Zhang; Jiangbin Wang
Journal:  Hepat Mon       Date:  2016-05-28       Impact factor: 0.660

Review 3.  Diagnosis and Clinical Implications of Diabetes in Liver Cirrhosis: A Focus on the Oral Glucose Tolerance Test.

Authors:  Tsutomu Nishida
Journal:  J Endocr Soc       Date:  2017-05-23

4.  Estimation of homeostatic dysregulation and frailty using biomarker variability: a principal component analysis of hemodialysis patients.

Authors:  Yuichi Nakazato; Tomoko Sugiyama; Rena Ohno; Hirofumi Shimoyama; Diana L Leung; Alan A Cohen; Riichi Kurane; Satoru Hirose; Akihisa Watanabe; Hiromi Shimoyama
Journal:  Sci Rep       Date:  2020-06-25       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.